文献速递流行病学与生物统计真实世界研究与卫生经济

整合已发表预后评分用于观察性研究因果推断

On the aggregation of published prognostic scores for causal inference in observational studies.
PubMed 文献 · Stat Med · 2020-02-05

本文针对观察性研究中预后评分(PGS)分析因控制组样本有限而面临过拟合与简约性困境的问题,提出将预测模型聚合方法扩展至PGS分析,通过整合已发表预后模型构建「元评分」。模拟研究显示,聚合现有PGS形成的元评分对模型误设具有稳健性,即使基础评分遗漏混杂因素或关注不同结局。方法在哮喘治疗场景中进行了示例应用。

要点

  • PGS分析需在对照组开发多变量预后模型并外推至各治疗组。
  • 大型预后模型开发队列不总是可得,模型面临过拟合与简约性两难。
  • 将已发表PGS聚合为元评分可提升泛化性且对误设稳健。

核心结论

  • 将已有预后评分聚合为元评分用于观察性研究的PGS分析,对模型误设具有稳健性。

研究设计与样本

  • 方法学文章,扩展预测模型聚合方法至非随机研究的PGS分析,并进行广泛模拟及哮喘治疗数据示例。

主要发现

  • 模拟显示聚合已有PGS为元评分对误设稳健,即使基础评分错误遗漏混杂因素或关注不同结局。
  • 聚合方法在有限个体参与者数据下仍可考虑大量协变量并提升PGS泛化性。

临床怎么用

  • 在观察性因果推断中,当缺乏大型队列开发预后模型时,可考虑聚合已发表预后模型构建元评分以调整混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As real world evidence on drug efficacy involves nonrandomized studies, statistical methods adjusting for confounding are needed. In this context, prognostic score (PGS) analysis has recently been proposed as a method for causal inference. It aims to restore balance across the different treatment groups by identifying subjects with a similar prognosis for a given reference exposure ("control"). This requires the development of a multivariable prognostic model in the control arm of the study sample, which is then extrapolated to the different treatment arms. Unfortunately, large cohorts for developing prognostic models are not always available. Prognostic models are therefore subject to a dilemma between overfitting and parsimony; the latter being prone to a violation of the assumption of no unmeasured confounders when important covariates are ignored. Although it is possible to limit overfitting by using penalization strategies, an alternative approach is to adopt evidence synthesis. Aggregating previously published prognostic models may improve the generalizability of PGS, while taking account of a large set of covariates-even when limited individual participant data are available. In this article, we extend a method for prediction model aggregation to PGS analysis in nonrandomized studies. We conduct extensive simulations to assess the validity of model aggregation, compared with other methods of PGS analysis for estimating marginal treatment effects. We show that aggregating existing PGS into a "meta-score" is robust to misspecification, even when elementary scores wrongfully omit confounders or focus on different outcomes. We illustrate our methods in a setting of treatments for asthma.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Nguyen TL, Collins GS, Pellegrini F, et al. On the aggregation of published prognostic scores for causal inference in observational studies. Stat Med. 2020. PMID: 32022311. doi:10.1002/sim.8489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。